CDDRX
Price
$37.64
Change
+$0.06 (+0.16%)
Updated
Oct 6 closing price
Net Assets
45.57B
RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

CDDRX vs RMFCX

Header iconCDDRX vs RMFCX Comparison
Open Charts CDDRX vs RMFCXBanner chart's image
Columbia Dividend Income Inst2
Price$37.64
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets45.57B
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
CDDRX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
CDDRX vs. RMFCX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDDRX is a Buy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. CDDRX (45.6B). CDDRX pays higher dividends than RMFCX: CDDRX (1.61) vs RMFCX (1.20). CDDRX was incepted earlier than RMFCX: CDDRX (13 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than CDDRX (0.58). RMFCX is a more actively managed with annual turnover of: 31.00 vs. CDDRX (16.00). CDDRX has a lower initial minimum investment than RMFCX: CDDRX (0) vs RMFCX (250). RMFCX (7.44) and CDDRX (7.23) have marching annual gain over last year. CDDRX return over 5 years is better than : 69.75 vs. RMFCX (60.80).
CDDRXRMFCXCDDRX / RMFCX
Total Expense Ratio0.580.9164%
Annual Report Gross Expense Ratio0.580.9164%
Fund Existence13 years23 years-
Gain YTD13.13014.96488%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets45.6B112B41%
Annual Yield % from dividends1.611.20134%
Returns for 1 year7.237.4497%
Returns for 3 years47.3243.84108%
Returns for 5 years69.7560.80115%
Returns for 10 years130.8094.21139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.